Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

1.

Empirical relations between sense of coherence and self-efficacy, National Danish Survey.

Trap R, Rejkjær L, Hansen EH.

Health Promot Int. 2015 Jun 11. pii: dav052. [Epub ahead of print]

PMID:
26069296
2.

Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey.

Nsabagasani X, Ogwal-Okeng J, Mbonye A, Ssengooba F, Muhumuza S, Hansen EH.

J Pharm Policy Pract. 2015 May 11;8(1):18. doi: 10.1186/s40545-015-0038-2. eCollection 2015.

3.

Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicines.

Warrer P, Jensen PB, Aagaard L, Jensen LJ, Brunak S, Krag MH, Rossing P, Almdal T, Andersen HU, Hansen EH.

J Res Pharm Pract. 2015 Apr-Jun;4(2):64-72. doi: 10.4103/2279-042X.155753.

4.

Effects of field plot size on prediction accuracy of aboveground biomass in airborne laser scanning-assisted inventories in tropical rain forests of Tanzania.

Mauya EW, Hansen EH, Gobakken T, Bollandsås OM, Malimbwi RE, Næsset E.

Carbon Balance Manag. 2015 May 7;10:10. eCollection 2015 Dec.

5.

Prescription pain medications and chronic headache in Denmark: implications for preventing medication overuse.

Westergaard ML, Hansen EH, Glümer C, Jensen RH.

Eur J Clin Pharmacol. 2015 Jul;71(7):851-60. doi: 10.1007/s00228-015-1858-3. Epub 2015 May 14.

PMID:
25967539
6.

Medication overuse, healthy lifestyle behaviour and stress in chronic headache: Results from a population-based representative survey.

Westergaard ML, Glümer C, Hansen EH, Jensen RH.

Cephalalgia. 2015 Mar 24. pii: 0333102415578430. [Epub ahead of print]

PMID:
25804645
7.

Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA.

Eriksson R, Aagaard L, Jensen LJ, Borisova L, Hørlück D, Brunak S, Hansen EH.

Pharmacol Res Perspect. 2014 Jun;2(3):e00038. doi: 10.1002/prp2.38. Epub 2014 Apr 22.

8.

Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011.

Aagaard L, Hansen EH.

Int J Clin Pharm. 2014 Dec;36(6):1222-9. doi: 10.1007/s11096-014-0020-0. Epub 2014 Oct 7.

PMID:
25288145
9.

Patient safety culture in Norwegian primary care: a study in out-of-hours casualty clinics and GP practices.

Bondevik GT, Hofoss D, Hansen EH, Deilkås EC.

Scand J Prim Health Care. 2014 Sep;32(3):132-8. doi: 10.3109/02813432.2014.962791. Epub 2014 Sep 27.

10.

Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK.

Warrer P, Aagaard L, Hansen EH.

Drug Saf. 2014 Oct;37(10):805-13. doi: 10.1007/s40264-014-0215-2.

PMID:
25112669
11.

Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status.

Westergaard ML, Glümer C, Hansen EH, Jensen RH.

Pain. 2014 Oct;155(10):2005-13. doi: 10.1016/j.pain.2014.07.002. Epub 2014 Jul 11.

PMID:
25020001
12.

Vanillin formation from ferulic acid in Vanilla planifolia is catalysed by a single enzyme.

Gallage NJ, Hansen EH, Kannangara R, Olsen CE, Motawia MS, Jørgensen K, Holme I, Hebelstrup K, Grisoni M, Møller BL.

Nat Commun. 2014 Jun 19;5:4037. doi: 10.1038/ncomms5037.

13.

The safety attitudes questionnaire - ambulatory version: psychometric properties of the Norwegian translated version for the primary care setting.

Bondevik GT, Hofoss D, Hansen EH, Deilkås EC.

BMC Health Serv Res. 2014 Mar 29;14:139. doi: 10.1186/1472-6963-14-139.

14.

A multistate model and an algorithm for measuring long-term adherence to medication: a case of diabetes mellitus type 2.

Jensen ML, Jørgensen ME, Hansen EH, Aagaard L, Carstensen B.

Value Health. 2014 Mar;17(2):266-74. doi: 10.1016/j.jval.2013.11.014.

PMID:
24636386
15.

Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials.

Aagaard L, Hansen EH.

Int J Clin Pharm. 2014 Apr;36(2):243-52. doi: 10.1007/s11096-014-9924-y. Epub 2014 Feb 23. Review.

PMID:
24562976
16.

Ethnic and migrant differences in the use of anti-asthmatic medication for children: the effect of place of residence.

Cantarero-Arévalo L, Ersbøll AK, Holstein BE, Andersen A, Kaae S, Hansen EH.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):95-104. doi: 10.1002/pds.3541. Epub 2013 Oct 23.

PMID:
24395546
17.

Immigrant background and medicine use for aches: national representative study of adolescents.

Cantarero-Arévalo L, Holstein BE, Andersen A, Kristiansen M, Hansen EH.

J Pharm Policy Pract. 2014 Jan 22;7:1. doi: 10.1186/2052-3211-7-1. eCollection 2014.

18.

Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review.

Westergaard ML, Hansen EH, Glümer C, Olesen J, Jensen RH.

Cephalalgia. 2014 May;34(6):409-25. doi: 10.1177/0333102413512033. Epub 2013 Nov 29. Review.

PMID:
24293089
19.

Adverse drug reactions in children reported by European consumers from 2007 to 2011.

Aagaard L, Hansen EH.

Int J Clin Pharm. 2014 Apr;36(2):295-302. doi: 10.1007/s11096-013-9874-9. Epub 2013 Nov 5.

PMID:
24190692
20.

Dependence and withdrawal reactions to benzodiazepines and selective serotonin reuptake inhibitors. How did the health authorities react?

Nielsen M, Hansen EH, Gøtzsche PC.

Int J Risk Saf Med. 2013;25(3):155-68. doi: 10.3233/JRS-130594.

PMID:
24047687
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk